Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-center, Randomized, Double Blind, Dose Escalation Safety Study of MP4CO in Clinically Stable Adult Sickle Cell Patients

NCT01356485 is registered in ClinicalTrials.gov with Sangart as lead sponsor.

NCT NCT01356485
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01356485 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-center, Randomized, Double Blind, Dose Escalation Safety Study of MP4CO in Clinically Stable Adult Sickle Cell Patients
Lead sponsor
Sangart
Phase
Phase 1
Overall status
Completed
Start date
January 31, 2012
Completion date
December 31, 2012
Enrollment
32 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

anemia, sickle cell, hemoglobin sc disease, sickle cell anemia, sickle cell disease, sickle cell disorders, sickle cell hemoglobin c disease